TABD Companies Urge Governments to Drive Innovation

The TransAtlantic Business DialogueThe TransAtlantic Business Dialogue (TABD) held its Innovation Conference Healthcare under the patronage of German Chancellor Angela Merkel, who has made transatlantic innovation a key tenet of the EU presidency. The conference, which brought together American and European participants, including political leaders and scientific experts, presented four recommendations to improve innovation in healthcare and healthcare delivery.

Speakers at the TABD conference, noting aging demographics and escalating healthcare costs on both sides of the Atlantic, urged the European Union and the U.S. Government to:

  • Recognize healthcare as an infrastructure component that serves as both the means to improve people's health and well-being and a key economic driver;
  • Accelerate the deployment of healthcare innovations by harmonizing standards, streamlining approval processes and protecting intellectual property rights;
  • Foster innovation and redirect financial incentives to focus on prevention, early detection and continuity of care; and
  • Establish an expert panel to develop benchmarking and best practices, working with the European Commission, the U.S. Government and the TABD Innovation Working Group.

Among OECD countries, the healthcare sector will more than triple to $10 trillion by 2020, according to "HealthCast 2020: Creating a Sustainable Future," a report by PricewaterhouseCoopers. The report stated that the healthcare sector is challenged by a confluence of powerful trends that include increasing demands, rising costs, uneven quality and misaligned incentives.

"Our aging populations and rising demand for higher-quality care accentuate the inefficiencies across the healthcare spectrum," said Klaus Kleinfeld, President and CEO of Siemens AG and Co-Chair of the TABD Innovation Working Group. "Consequently, we need to put the patient at the center of an improved healthcare system by developing and deploying innovations in technology and service delivery."

Richard T. Clark, Chairman, President and CEO of Merck & Co., Inc. (USA) and Cochair of the Innovation Working Group called for developing new ways of thinking about healthcare investment and spending. "Advances in medical technology and patient care set the stage to deliver prevention instead of treatment. As we build this capability, we want governments and other financial providers to think of healthcare spending as an investment that should be encouraged – not as a cost to be managed."

Speakers at the event included German Federal Minister of Education and Research Annette Schavan; European Commission Vice President Günter Verheugen; Deputy Secretary of the U.S. Department of Commerce David A. Sampson, Hans Hoogervorst former Minister of Health, Welfare and Sports, The Netherlands; and Newt Gingrich, Founder of the Center for Health Transformation and former Speaker, U.S. House of Representatives.

About the TransAtlantic Business Dialogue Innovation Conference Healthcare
As Co-Chairmen of the TransAtlantic Business Dialogue (TABD) Innovation Working Group Klaus Kleinfeld, CEO Siemens AG, and Richard Clark, Chairman, President and CEO of Merck & Co. Inc. (USA) co-hosted the TABD Innovation Conference Healthcare in Berlin on May 8, 2007. The TABD Innovation Conference was organized by the TABD and sponsored by AstraZeneca, General Electric, Microsoft, Merck Sharp & Dohme (MSD), Pfizer, Philips, PricewaterhouseCoopers and Siemens AG.

About the TransAtlantic Business Dialogue
The TABD brings together the CEOs of more than 30 European and U.S. companies operating in the United States, Europe and globally, with the aim of promoting closer commercial ties between the US and the European Union. The current TABD Chairmen are Martin Broughton, Chairman of British Airways and Charles Prince, Chairman and Chief Executive Officer of Citigroup. Originally launched with the support of the U.S. Department of Commerce and the European Commission in Seville in 1995, it was relaunched in a new format in 2003. The TABD is a unique and effective organization whose primary goal is to help establish a barrier-free transatlantic market with the freest possible exchange of goods, services and capital between the EU and US. The TABD advocates global trade liberalization as a means to greater prosperity for all countries, which in turn will help stimulate innovation, investment, economic growth, and job creation.

For further information, please visit:

Related news articles::

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...